Radiopharmaceuticals | Administered activity MBq (mCi) | Organ receiving the largest radiation dose MGy/MBq (rad/mCi) | Effective dose MSv/MBq (rem/mCi) |
---|---|---|---|
99mTc-DTPA* | 555–740 i.v. (15–20) | 0.065 bladder wall (0.24) | 0.0063 (0.023) |
99mTc-HMPAO† | 370–1110 i.v. (10–30) | 0.034 kidneys (0.0126) | 0.0093 (0.034) |
99mTc-ECD‡ | 370–1110 i.v. (10–30) | 0.073 bladder wall (0.27) | 0.011 (0.042) |
↵* ICRP 53, page 188.
↵† ICRP 62, page 13.
↵‡ Radiation Dose Estimates for Radiopharmaceuticals; Radiation Internal Dose Information Center, Oak Ridge Institute for Science and Education, Oak Ridge, TN; http://www.orau.gov/ehsd/DOSETABLES.doc.
i.v. = intravenously.